HeartSciences Inc.
HSCS
$3.46
$0.113.28%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.26% | -25.20% | -18.58% | -3.95% | 5.66% |
| Total Depreciation and Amortization | -4.10% | 2.63% | -5.07% | 4.43% | 578.57% |
| Total Amortization of Deferred Charges | 69.88% | 4.58% | -- | 68.73% | -43.76% |
| Total Other Non-Cash Items | -62.48% | -31.94% | 42.24% | 164.01% | 1,102.50% |
| Change in Net Operating Assets | 140.23% | -554.62% | -294.63% | -880.58% | -183.85% |
| Cash from Operations | -15.79% | -48.64% | -23.82% | -4.44% | -24.51% |
| Capital Expenditure | -123.18% | -237.78% | -481.08% | -252.46% | -117.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.02% | -- | -1,881.63% | -- | -- |
| Cash from Investing | -107.06% | -818.89% | -910.00% | -805.46% | -495.33% |
| Total Debt Issued | 453.65% | 453.65% | -- | -- | -57.70% |
| Total Debt Repaid | 21.26% | 39.98% | 35.34% | 26.77% | -22.55% |
| Issuance of Common Stock | -87.66% | 332.78% | 397.64% | 48.95% | 122.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | -73.97% | 416.21% | 527.18% | 58.29% | 102.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -187.06% | 232.80% | 201.82% | 458.78% | 753.62% |